Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney DiseaseNews DeskApril 14, 20260 The journey of a Travere Therapeutics drug has culminated in a long-awaited FDA approval, making the once-daily pill the first…
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune DisorderNews DeskMarch 29, 20260 A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a…
FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating DrugsNews DeskMarch 26, 20260 Hunter syndrome patients can manage the disorder with a drug that addresses disease symptoms throughout the body except the brain…